首页> 外国专利> METHOD FOR TREATMENT OF REFRACTIVE AMBLYOPIA

METHOD FOR TREATMENT OF REFRACTIVE AMBLYOPIA

机译:治疗屈光弱视的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to ophthalmology. Transcutaneous electrical stimulation of the retina and optic nerve and presentation of a black-and-white pattern are performed. Every day for 10 days, a course of treatment is carried out on a binocular optical complex. Meridional pattern-stimulation in the presence of meridional asymmetry or multifocal pattern-stimulation in its absence, corresponding to the maximally corrected visual acuity of the patient. In this case, the test objects in the form of a pattern are reduced during the 10-day treatment with an increase in visual acuity. The central element of the pattern is made in the form of a checkerboard with multifocal pattern stimulation and in the form of black and white stripes, located depending on the axis of astigmatism, with meridional pattern stimulation. The pattern is presented monocularly for 30 min for each eye. The patient observes the central element of the pattern and identifies squares in the case of a checkerboard or a strip in the case of meridional pattern stimulation. Also, transcutaneous electrical stimulation of the retina and optic nerve is carried out on the ESOFI-1 apparatus with the patient's eyes closed with a threshold of electrical sensitivity and lability of the optic nerve from 20 to 40 Hz and a current from 80 to 140 mA, which is fed through closed eyelids to the patient's interested eye for 1 minute, as well as photomagnetostimulation on the CMS-12 apparatus for 2 minutes in the projection of the orbit and for 2 minutes in the occipital region in the projection of the visual cortex. General illumination of the retina on the MBS-02 apparatus for 2 minutes and electrophoresis on the PoTok apparatus alternately for 1 day with riboflavin, 1 day with euphilin for 10 minutes. In total, one to seven courses of treatment are carried out, with a break of 2-3 months between courses.;EFFECT: invention allows treating refractive amblyopia, increasing the maximum corrected visual acuity.;1 cl, 3 ex
机译:田地:药物。物质:发明涉及药物,即眼科。进行视网膜和视神经的经皮电刺激和黑白图案的呈递。每天10天,在双目光学络合物上进行治疗过程。在不存在子午相的不对称或多焦点模式刺激的情况下,对应于患者的最大矫正视力的子午相刺激。在这种情况下,在10天的治疗期间,在10天的治疗中减少了一种模式的测试对象,随着视力的增加。图案的中心元素以棋盘的形式制成,具有多焦点刺激,并且以黑白条纹的形式,根据像散的轴线,具有子午线模式刺激。每只眼睛将图案呈现30分钟。患者观察图案的中心元素,并在子午样刺激的情况下在棋盘的情况下识别正方形。此外,视网膜和视神经的经皮电刺激在ESOFI-1设备上进行,患者的眼睛闭合,阈值,光神经的阈值,从20至40Hz的光神经的宽度和80至140 mA的电流,它通过封闭的眼睑喂养给患者感兴趣的眼睛1分钟,并且在CMS-12装置上刺激刺激,在视觉皮层投射的投影中的枕骨区域中的2分钟内2分钟。在MBS-02的视网膜上的一般照射2分钟和POTOK装置的电泳交替用核黄素1天,用奎林1天10分钟。总共进行一到七个治疗课程,术后突破2-3个月。;效果:发明允许治疗折衷弱视,增加最大校正的视力。; 1 cl,3前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号